All Pharma News
Tessa Therapeutics dissolves after raising more than $200M

Tessa Therapeutics dissolves after raising more than $200M
Max Bayer FIERCE BIOTECH
06 Jul 2023
Share Share
Tessa Therapeutics Announces Positive Results from CD30 CAR-T Combination

Tessa Therapeutics Announces Positive Results from CD30 CAR-T Combination
GLOBENEWSWIRE
16 Jun 2023
Share Share
Tessa Therapeutics™ Off-the-Shelf™ CAR-T Therapy Shows Promising Results

Tessa Therapeutics™ Off-the-Shelf™ CAR-T Therapy Shows Promising Results
GLOBENEWSWIRE
15 Jun 2023
Share Share
Tessa Therapeutics™ Autologous and Allogeneic Cell Therapy Data

Tessa Therapeutics™ Autologous and Allogeneic Cell Therapy Data
GLOBENEWSWIRE
30 May 2023
Share Share
Tessa Therapeutics Enters into CRADA with the U.S. National Cancer Institute

Tessa Therapeutics Enters into CRADA with the U.S. National Cancer Institute
GLOBENEWSWIRE
08 Mar 2023
Share Share
Tessa Therapeutics Enters CRADA with the National Cancer Institute

Tessa Therapeutics Enters CRADA with the National Cancer Institute
CONTRACT PHARMA
08 Mar 2023
Share Share
Tessa`s New Year resolutions is to opt for allogeneic CAR-T

Tessa`s New Year resolutions is to opt for allogeneic CAR-T
Max Bayer FIERCE BIOTECH
03 Jan 2023
Share Share
Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023

Tessa Therapeutics Provides Strategic Outlook and Corporate Update for 2023
GLOBENEWSWIRE
03 Jan 2023
Share Share
Tessa Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial

Tessa Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial
GLOBENEWSWIRE
12 Dec 2022
Share Share
Tessa Therapeutics Announces Data from Phase 1 Allogeneic Study Presented at ASH

Tessa Therapeutics Announces Data from Phase 1 Allogeneic Study Presented at ASH
GLOBENEWSWIRE
10 Dec 2022
Share Share